The global epigenomic market was valued US$ 5.28 Bn in 2017 and is expected to reach US$ 16.3 Bn by 2026, at a CAGR of 15.13 % during a forecast period.
Increase in the prevalence of cancer & other chronic diseases, a rise in the aging population, and a decrease in the sequencing costs & time is driving the growth of the market. Growth in funding for research & development, need for better cancer therapies, development in personalized medicine, and the increasing importance of epigenetic technology is also boosting the market growth. The high cost of instruments is limiting the growth of the market. Some challenges of the market are concerns regarding the quality of antibodies, and a lack of trained professionals.
Reagents segment include antibodies, buffers, histones, and magnetic beads. Reagents are used in the analysis of epigenetic changes and it is contributed the maximum shares to the this market owing to the sales volume of reagents is high in comparison to other equipment. The sales volume of reagents is high due to their increased affordability & ease of storage in less space. Oncology deals with tumors and cancers.
Rise in the number of collaborations between the large pharmaceutical companies to get into innovation & produce technologically advanced and effective products & service in North-America is leading the global market. An Asia-pacific this is estimated to grow rapidly, owing to the high incidence of cancer, a large occurrence of target diseases, the rise in healthcare expenditure, the increase in investments & funds, and various emerging applications.
For More Information Visit@ https://www.maximizemarketresearch.com/market-report/global-epigenomic-market/22165/
The Scope of Global Epigenomic Market:
Global Epigenomic Market, by Product:
• Instruments and Consumables
• Bioinformatics Tools
Global Epigenomic Market, by Application:
• Metabolic Diseases
• Developmental Biology
• Cardiovascular Diseases
• Other application
Global Epigenomic Market, by Technology:
• DNA Methylation
• Histone Modifications
• Other Technologies
Global Epigenomic Market, by End-User:
• North America
• South America
• Middle East & Africa
Key Player Operating In the Global Epigenomic Market:
• Abbott Laboratories
• Agilent Technologies
• Astellas Pharmaceuticals
• Bayer Ag
• Bio Vision
• Celgene Corp.
• Epigenomics Ag
• Illumina Inc.
• Johnson & Johnson
• Laboratory Corp. Of America Holdings
• Merck Sharp & Dohme
• Naturewise Biotech & Medicals Corp.
• Novartis Pharma Ag
• Orchid Chemicals & Pharmaceuticals Limited
• Tbg Diagnostics Limited
• Rubicon Genomics
• Roche Holding Ag
This Report Is Submitted By @ Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.